RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of an independent, third-party test that indicates the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.9% of the SARS-CoV-2 virus in the air and on inoculated surfaces.
PORT OF PALM BEACH, Fla., Feb. 26, 2021 /PRNewswire/ -- RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of an independent, third-party test that indicates the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.9% of the SARS-CoV-2 virus in the air and on inoculated surfaces. SARS-CoV-2, commonly known as coronavirus, is the virus that causes COVID-19. Given the CDC’s determination that SARS-CoV-2 is an airborne virus, meaning it spreads from person-to-person via aerosols and respiratory particles, the test results are important for building owners and operators seeking a proven solution to combat SARS-CoV-2 in the air and on surfaces inside the occupied or air-conditioned space. “SARS-CoV-2 virus particles or aerosols are produced when an infected person coughs, sneezes or talks. Large virus particles fall out of the air and onto surfaces, resulting in surface contamination, however small virus particles can stay airborne for hours,” noted Dr. James Marsden, Executive Director of Science & Technology at RGF® Environmental Group. “Similar to RGF’s REME HALO®, the PHI-PKG14 PHI-CELL® neutralizes greater than 99.9% of the SARS-CoV-2 virus in the air and on contaminated surfaces.” Testing Protocols and Results Testing of the PHI-PKG14 PHI-CELL® active air purification system indicated that the SARS-CoV-2 virus is significantly neutralized within the occupied space, and significantly reduced risk of person-to-person infection by respiratory particles and aerosols. The PHI-PKG14 PHI-CELL® eliminated the need for virus particles to travel through the HVAC system filters or UV air purification system. PHI-PKG14 PHI-CELL® Product Overview and Applications DISCLAIMER: The summary and any comments herein are based on the results from an independent laboratory study performed under controlled conditions and are not in any way medical claims. The product(s) and technologies described are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, virus or illness. For more information or to schedule an interview, please contact Stan Wagner at stan@themaverickpr.com or 303-618-5080. About RGF® Environmental Group, Inc.
SOURCE RGF Environmental Group, Inc. |